Clinical relationship between MDR1 gene and gallbladder cancer

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 2, 2004, Pages 296-299

  Wang, Bai Lin ^a   Zhai, Hai Ying ^b   Chen, Bing Yi ^c   Zhai, Shu Ping ^a   Yang, Hai Yan ^a   Chen, Xiao Ping ^d   Zhao, Wen Tao ^a   Meng, Lei ^e  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b First People's Hospital of Jining   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e NONE

Author keywords

Drug resistance; Gallbladder neoplasms; Gene; Multiple

Indexed keywords

ANTINEOPLASTIC AGENT; BIOCHEMICAL MARKER; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CARCINOGENESIS; CHOLECYSTITIS; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; GALLBLADDER CANCER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR DIFFERENTIATION;

ADULT; AGED; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; FEMALE; GALLBLADDER NEOPLASMS; GENES, MDR; HUMANS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PROGNOSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 2442680353     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Wu H, Hait WN, Yang JM. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistance cancer cells. Cancer Res 2003; 63: 1515-1519.
2. Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N, et al. NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 2003;22:90-97.
3. Tokunaga Y, Hosogi H, Hoppou T, Nakagami M, Tokuka A, Ohsumi K. Effects of MDR1/P-glycoprotein expression on prognosis in advanced colorectal cancer after surgery. 2001;8: 815-819.
4. Schondorf T, Neumann R, Benz C, Becker M, Riffelmann M, Gohring UJ, et al. Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines. Recent Results Cancer Res 2003;161:111-116.
5. Potocnik U, Glavac MR, Golouh R, Glavac D. The role of P-glycoprotein (MDR1) polymorphisms and mutations in colorectal cancer. Pflugers Arch 2001;442(6 Suppl 1):R182-183.
6. Faneyte IF, Kristel PM, van de Vijver MJ. Determining MDR1/P-glycoprotein expression in breast cancer. Int J Cancer 2001;93:114-122.
7. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE. Overexpression of a transporter gene in a multidrug resistant human lung cancer line. Science 1992;258:1650-1657.
8. Gottesman MM, Pastan I, Ambudkar SV. P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 1996;6:610-617.
9. Nakayama K, Kanzaki A, Ogawa K, Miyazaki K, Neamati N, Takebayashi Y. Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. Int J Cancer 2002; 101:488-495.
10. Wang BL, Chen XP, Zhai SP, Chen DF. Clinical significance of mrp gene in primary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2003;3:397-403.
11. Shi JS, Wang JS, Liu G, Yu YL, LU Y, Jiao XY, et al. Early diagnosis of primary gallbladder carcinoma. Hepatobiliary Pancreat Dis Int 2002;1:273-275.
12. Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinoma of the gallbladder. Results of French Surgical Association. Survey Ann Surg 1994;219:275-280.
13. Gall FP, Kockerling F, Scheeve J, Schneider C, Hohenberger W. Radical operation for carcinoma of gallbladder present status. In Germany. World J Surg 1991;15:328-336.
14. Pradeep R, Kaushik SP, Sikora SS, Bhattacharya BN, Pandey CM, Kapoor VK. Predictors of survival in patients with carcinoma of the gallbladder. Cancer 1995;76:1145-1149.
15. Yang X, Uziely B, Groshen S, Lukas J, Israel V, Russell C, et al. MDR1 gene expression in primary and advanced breast cancer. Lab Invest 1999;79:271-280.
16. Schondorf T, Kurbacher CM, Gohring UJ, Benz C, Becker M, Sartorius J, et al. Induction of MDR1-gene expression by antineoplastic agents in ovarian cancer cell lines. Anticancer Res 2002;22:2199-2203.
17. Schneider J, Gonzalez-Roces S, Pollan M, Lucas R, Tejerina A, Martin M, et al. Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy. Breast Cancer Res 2001;3:183-191.
18. Cowan KH, Moscow JA, Huang H, Zujewski JA, O'Shaughnessy J, Sorrentino B, et al. Paclitaxel chemotherapy after autologious stem-cell transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin Cancer Res 1999;5:1619-1628.
19. Lu Z, Kleeff J, Shrikhande S, Zimmermann T, Korc M, Friess H, et al. Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer. Pancreas 2000;21:240-247.
20. Tada Y, Wada M, Kuroiwa K, Kinugawa N, Harada T, Nagayama J, et al. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment. Clin Cancer Res 2000;6:4618-4627.
21. Parissenti AM, Gannon BR, Villeneuve DJ, Kirwan-rhude AF, Chadderton A, Gluck S. Lack of modulation of MDR1 gene expression by dominant inhibition of camp-dependent protein kinase in doxrubicin-resistant MCF-7 breast cancer cells. Int J Cancer 1999;82:893-900.
22. Lizard-nacol S, Genne P, Coudert B, Riedinger JM, Arnal M, Sancy C, et al. MDR1 and thymidylate synthase (TS) gene expressions in advanced breast cancer: relationships to drug exposure, P53 mutations, and clinical outcome of the patients. Anticancer Res 1999;19:3575-3581.
23. Arnal M, Franco N, Fargeot P, Riedinger JM, Brunet-Lecomten P, Lizard-Nacol S. Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer. Breast Cancer Res Treat 2000;61:13-20.
24. Schneider J, Lucas R, Sanchez J, Ruibal A, Tejerina A, Martin M. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP. Anticancer Res 2000;20:4373-4377.
25. Huang ZQ Tumor of the biliary tract. In: Wu JP, Qiu FZ (eds). Huang Jia Si Surgery, 6th ed. Beijing: People Medical Press; 2000:1291.
26. Cao L, Duchrow M, Windhovel U, Kujath P, Bruch HP, Broll R. Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gallbladder cancer tissues. Eur J Cancer 1998;34:1612-1617.
27. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265-269.
28. Yu LF, Wu YL. Clinical relationship of study advances between multidrug gene and digestive tumor. WCJD 1998; 6: 915-916.
29. Cao L, Peng S, Duchrow M. Expression of P-glycoprotein in benign and malignant gallbladder neoplasms. Zhonghua Zhong Liu Za Zhi 1999;21:119-121.
30. Zou S, Zhang L, Zen G, Chen J, Xia S. Clinical epidemiologic characteristics of 430 cases of gallbladder cancer. Chin Med J (Engl) 1998;111:391-393.